Metabolic indices in schizophrenia: Association of negative symptoms with higher HDL cholesterol in female patients
- 1 December 2020
- journal article
- other
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 22 (7) , 552-556
Abstract
Negative symptoms of schizophrenia can be related to metabolic abnormalities. The study aimed to assess negative symptoms using the Positive and Negative Syndrome Scale (PANSS) and the Brief Negati...Keywords
This publication has 23 references indexed in Scilit:
- Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysisSchizophrenia Research, 2017
- Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic SchizophreniaJournal of Clinical Psychopharmacology, 2016
- Obesity and the Neurocognitive Basis of Food Reward and the Control of IntakeAdvances in Nutrition, 2015
- Estrogen Deficiency and the Origin of Obesity during MenopauseBioMed Research International, 2014
- Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: Severe negative syndrome may be related to a distinct lipid pathophysiologyEuropean Psychiatry, 2014
- The Brief Negative Symptom Scale: Psychometric PropertiesSchizophrenia Bulletin, 2010
- Association of Initial Antipsychotic Response to Clozapine and Long-Term Weight GainAmerican Journal of Psychiatry, 2006
- Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improvedActa Psychiatrica Scandinavica, 2005
- Clozapine-induced weight gain predicts improvement in psychopathologySchizophrenia Research, 2003
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987